Glaukos vs Transmedics Group
Transmedics Group is the larger business, with $605m of revenue in fiscal 2025 against $507m for Glaukos (1.2 times as much). Transmedics Group grew faster (37.1% against 32.3%). Transmedics Group kept more of each dollar of sales as profit: a net margin of 31.4% against -37.0%. Glaukos carries less debt relative to equity (0.0% against 97.8%).
| Latest fiscal year | GlaukosGKOS, 2025 | Transmedics GroupTMDX, 2025 |
|---|---|---|
| Revenue | $507m | $605m |
| Revenue growth | 32.3% | 37.1% |
| Net income | −$188m | $190m |
| Operating margin | -39.3% | 17.9% |
| Net margin | -37.0% | 31.4% |
| Return on equity | -26.4% | 54.2% |
| Free cash flow | −$22.5m | $134m |
| Cash | $90.8m | $489m |
| Total debt | $0 | $463m |
| Debt to equity | 0.0% | 97.8% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 1,094 | 898 |
| Market value | $14.03bn | $2.33bn |
| Price vs our value range | — | — |
| Moat score | 28 (Weak) | 33 (Weak) |
| Insider trades, 12 months | 0 buys, 61 sales | 2 buys, 11 sales |